SIHUAN PHARMACE (TEL1.SG)
SIHUAN PHARMACE (TEL1.SG) operates in Diversified Metals & Mining.
Market Cap & Net Worth: SIHUAN PHARMACE (TEL1.SG) (TEL1)
SIHUAN PHARMACE (TEL1.SG) (STU:TEL1) has a market capitalization of $1.53K (€1.49K) as of March 19, 2026. Listed on the STU stock exchange, this Germany-based company holds position #47697 globally and #8008 in its home market, demonstrating a 7.80% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SIHUAN PHARMACE (TEL1.SG)'s stock price €0.15 by its total outstanding shares 9807 (9.81K).
SIHUAN PHARMACE (TEL1.SG) Market Cap History: 2015 to 2026
SIHUAN PHARMACE (TEL1.SG)'s market capitalization history from 2015 to 2026. Data shows growth from $405.68 to $1.53K (13.94% CAGR).
SIHUAN PHARMACE (TEL1.SG) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SIHUAN PHARMACE (TEL1.SG)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
SIHUAN PHARMACE (TEL1.SG)'s market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $318.11 | $3.19 Billion | $1.71 Billion | 0.00x | 0.00x |
| 2017 | $440.92 | $2.75 Billion | $1.45 Billion | 0.00x | 0.00x |
| 2018 | $231.53 | $2.92 Billion | $1.62 Billion | 0.00x | 0.00x |
| 2019 | $186.23 | $2.89 Billion | -$2.75 Billion | 0.00x | N/A |
| 2020 | $239.59 | $2.46 Billion | $473.38 Million | 0.00x | 0.00x |
| 2021 | $502.32 | $3.04 Billion | $416.51 Million | 0.00x | 0.00x |
| 2022 | $389.58 | $2.18 Billion | -$1.91 Billion | 0.00x | N/A |
| 2023 | $407.70 | $1.86 Billion | -$54.02 Million | 0.00x | N/A |
Competitor Companies of TEL1 by Market Capitalization
Companies near SIHUAN PHARMACE (TEL1.SG) in the global market cap rankings as of March 19, 2026.
Key companies related to SIHUAN PHARMACE (TEL1.SG) by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
SIHUAN PHARMACE (TEL1.SG) Historical Marketcap From 2015 to 2026
Between 2015 and today, SIHUAN PHARMACE (TEL1.SG)'s market cap moved from $405.68 to $ 1.53K, with a yearly change of 13.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.53K | +23.58% |
| 2025 | €1.24K | +75.71% |
| 2024 | €704.66 | +72.84% |
| 2023 | €407.70 | +4.65% |
| 2022 | €389.58 | -22.44% |
| 2021 | €502.32 | +109.66% |
| 2020 | €239.59 | +28.65% |
| 2019 | €186.23 | -19.57% |
| 2018 | €231.53 | -47.49% |
| 2017 | €440.92 | +38.61% |
| 2016 | €318.11 | -21.59% |
| 2015 | €405.68 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SIHUAN PHARMACE (TEL1.SG) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.53K USD |
| MoneyControl | $1.53K USD |
| MarketWatch | $1.53K USD |
| marketcap.company | $1.53K USD |
| Reuters | $1.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.